Polycythemia vera (PV) is a slow-growing blood cancer in which the bone marrow makes too many red blood cells on its own, without the usual signals from the body. Doctors diagnose it with a World Health Organization checklist that combines a blood count, a genetic test, and usually a look at the bone marrow. A high red cell count alone is not enough, because many ordinary things, such as smoking or sleep apnea, can also push it up.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review The checklist was loosened a few years ago, and that change revealed that many people had been living with PV without ever being diagnosed.2PubMed Central. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
The Three Major Criteria and the One Minor Criterion
- Major 1: hemoglobin above 16.5 g/dL in men or 16 g/dL in women, or hematocrit above 49% in men or 48% in women.3Blood Cancer Journal. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
- Major 2: a bone marrow sample showing the crowded, typical pattern of PV.3Blood Cancer Journal. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
- Major 3: a JAK2 gene change found in blood or marrow.3Blood Cancer Journal. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
- Minor: a blood erythropoietin (EPO) level below normal.3Blood Cancer Journal. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
Hemoglobin is the oxygen-carrying protein in red cells, and hematocrit is the share of your blood made up of red cells. Your lab report lists both, usually as Hb or HGB and Hct or HCT. Meeting either one satisfies the first criterion; you don’t need both. The cutoffs differ for men and women because normal levels differ by sex.
Doctors confirm PV when all three major criteria are met, or when the first two majors are met along with the minor one. The low-EPO route exists to catch the small group of people with PV who have no JAK2 change.3Blood Cancer Journal. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis A low EPO only counts when it is paired with the first two majors. In practice, many specialists make a working diagnosis from the JAK2 change plus high red cell numbers, treating the marrow test as advised rather than required.4PubMed. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management So you may be told you have PV before any marrow biopsy is done.
The usual order starts with a routine blood count that flags high hemoglobin or hematocrit, often by accident during a checkup. The JAK2 test and an EPO level typically come next, since they need only a blood draw. The marrow biopsy is then added or skipped, depending on those results and on what your hematologist thinks it would change.
If your counts are high but the JAK2 test is negative and EPO is normal, the checklist isn’t satisfied, and doctors keep looking for another explanation. A positive JAK2 test with counts under the cutoffs also doesn’t complete the checklist, but it usually prompts closer follow-up, since early PV can sit just under the line. Not meeting criteria today isn’t always a permanent answer, because counts can rise over time and tests may be repeated.
The JAK2 Gene Test
JAK2 is a gene that controls the signals telling the marrow to make blood cells. A change in it is called a JAK2 mutation. The most common one, called V617F, is acquired during life, not inherited, and marks a group of marrow cells growing on their own.5PubMed. Diagnosis and therapy of polycythemia vera Over 95% of people with PV have a JAK2 change.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review6PubMed. Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy
The test is usually a routine blood draw, with no marrow needed. Results often take one to two weeks, and your report may read “JAK2 V617F detected” or “not detected.” It isn’t passed to your children, and family members don’t need testing because of your result.
A detected JAK2 change in someone with persistently high red cell numbers strongly points to PV, but it is one piece of the checklist rather than the whole diagnosis. It doesn’t tell you how severe the disease is or how quickly it will progress. Some people carry a JAK2 change with only mildly raised counts, which is why doctors pair the result with your numbers and sometimes the marrow findings.
Most people without V617F carry a different JAK2 change in a section called exon 12.7PubMed. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera More than 50 such less-common changes have been found, and they seem to act like V617F.8Mayo Clinic Laboratories. Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing for Erythrocytosis Labs often test for V617F first and then automatically check exons 12 to 15 if it is negative.8Mayo Clinic Laboratories. Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing for Erythrocytosis Still, in people with high red cells from other causes, exon 12 changes turn up only about 1.4% of the time.9PubMed Central. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
If exon 12 and the nearby sections are also clear, PV becomes unlikely and doctors turn to other causes of high red cells. In that situation the EPO level and marrow findings carry more weight, since the rare PV without a JAK2 change is diagnosed by the low-EPO route.
What Your EPO Level Means
Erythropoietin, or EPO, is a hormone from the kidneys that tells the marrow to make red cells. In PV the body senses too many red cells and turns its EPO down. A low EPO therefore suggests the marrow is overproducing without being told to, while a normal or high level suggests a cause outside the marrow.10PubMed. Erythrocytosis: Diagnosis and investigation
Reports give EPO in mIU/mL or IU/L, which are the same scale. Compare your number with the lab’s own reference range printed on the report. A borderline result usually leads to more testing, not a final answer, and your doctor may repeat it if the first result is unclear.
EPO is measured on an ordinary blood sample, and many labs ask for no special preparation. Doctors sometimes want the sample taken before treatments such as blood removal, which can change the body’s EPO level.
A very low EPO strongly suggests PV, but many people with PV don’t have a level that low.11PubMed. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center The JAK2 test sorts PV from other causes much more reliably than EPO does.11PubMed. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center The cutoff a lab uses matters too: higher cutoffs catch more PV cases but also flag more people who don’t have it.12PubMed Central. Diagnostic Performance of Serum Erythropoietin to Discriminate Polycythemia Vera from Secondary Erythrocytosis through Established Subnormal Limits EPO alone isn’t a good screening test, and a normal result doesn’t rule PV out.11PubMed. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center
Where EPO matters most is when JAK2 is negative. Without a JAK2 change, a low EPO is one of the routes to diagnosis, and it helps decide whether to search for a hidden outside cause.
Do You Need a Bone Marrow Biopsy
PV marrow has a recognizable look that pathologists can identify consistently, and this led WHO to upgrade the marrow test from a minor to a major criterion.2PubMed Central. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion The biopsy shows how crowded the marrow is, any scarring, and the shape of the platelet-making cells.13Liaquat National Journal of Primary Care. Diagnosis and Treatment of Polycythemia Vera in Pakistan; Barriers and Possible Solutions
Under the microscope, pathologists check whether the marrow is more cellular than expected for your age, a crowded look in which red cell, white cell, and platelet precursors are all increased. They look at the platelet-making cells, which in PV often vary in size and cluster together. They also check for fibrosis, meaning scar-like fibers, which can be present early or develop later.
The sample is taken with a needle from the back of the hip bone, under local anesthetic in a clinic, in about 20 to 30 minutes. Soreness for a few days is common, and results usually take one to two weeks.
A JAK2 change with high counts and a low EPO often lets doctors make a working diagnosis, so a biopsy may be a second step rather than the first.13Liaquat National Journal of Primary Care. Diagnosis and Treatment of Polycythemia Vera in Pakistan; Barriers and Possible Solutions A biopsy is especially useful when counts are near the cutoffs or to tell PV from related marrow disorders.14PubMed. The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis It may also matter later: it sets a baseline for scarring, so later biopsies can be compared against it if the disease changes.
Other Causes of High Red Blood Cells
Causes of too many red cells outside the marrow include smoking, obstructive sleep apnea, living at high altitude, and heart disease that lowers oxygen.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review Some growths release EPO, including benign uterine fibroids and certain kidney or brain tumors.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review Because these raise EPO, they usually come with a normal or high EPO and no JAK2 change.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review
Two other causes are easy to overlook. Losing fluid concentrates the blood and can raise hematocrit temporarily, and diuretic medicines can do the same; a repeat test when well hydrated often comes back lower. Testosterone therapy commonly raises red cells too, so mention it, since it changes how results are read. That rise is not PV and has no JAK2 change.
Doctors start by asking about smoking, sleep, medicines, and where you live, because history often points to the cause before any test does. If the JAK2 test is negative and EPO is normal or high, the search moves toward oxygen problems or EPO-producing growths. Further testing, such as an oxygen check, a sleep study, or imaging, depends on what your history and first results suggest.10PubMed. Erythrocytosis: Diagnosis and investigation
When the cause is secondary, treating it, such as managing sleep apnea or quitting smoking, can bring the count down. PV is a different path: it is a marrow disease and needs its own monitoring and treatment.
Why the Cutoffs Were Lowered
The hemoglobin cutoff dropped from 18.5 to 16.5 g/dL in men and from 16.5 to 16 g/dL in women.15PubMed Central. Beyond Hemoglobin: When and How to Work Up Possible Polycythemia Vera In one hospital group, PV diagnoses rose by about two thirds under the newer rules.16PubMed Central. Contribution of lowered hemoglobin threshold value in the diagnosis of polycythemia vera: Comparison of 2016 and 2008 WHO criteria The new cutoffs also matched a more precise red cell measurement far better than the old ones did.17PubMed. The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology
The reason is early or masked PV. About a third of people with JAK2 and PV-type marrow had counts below the old cutoffs, which is what masked PV means.18PubMed. Masked polycythemia vera diagnosed according to WHO and BCSH classification These people tended to have shorter survival than people with obvious PV, likely because their disease went unrecognized.18PubMed. Masked polycythemia vera diagnosed according to WHO and BCSH classification They often feel unwell, with fatigue or itching, while their numbers look only slightly high.
In practice, more people now meet the first criterion, so a count once called merely high may start a PV work-up. The cutoffs are for diagnosing PV, not for screening everyone with a slightly high count.15PubMed Central. Beyond Hemoglobin: When and How to Work Up Possible Polycythemia Vera
If your number sits just above the cutoff, one reading isn’t a diagnosis, and doctors often repeat it. The JAK2 test is usually the next step, and being just over the line still deserves follow-up because of masked PV. Catching it early is worthwhile: early PV can already raise clot risk even when counts look modest, and a diagnosis lets doctors start monitoring and treatments such as aspirin or blood removal before problems arise.
A second system, the International Consensus Classification, is nearly identical, and you may see either named on reports. The main difference is an old red cell volume test that WHO dropped as impractical.19PubMed Central. Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification
Symptoms and Clot Risk After Diagnosis
About 8 in 10 people with PV have at least one symptom.20PubMed Central. Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival About a third have itching, often after a warm bath or shower, and about a third have an enlarged spleen.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review Fatigue and headache are common, and some notice brief vision changes or burning, red hands and feet.1PubMed Central. Diagnosis and Treatment of Polycythemia Vera: A Review
The itching often appears within minutes of contact with water and can last an hour or more without any visible rash. Fatigue can be significant and may not match how high your counts are. Headaches, dizziness, and ringing in the ears can come from thickened blood slowing circulation. Symptoms help doctors judge how well treatment is working even when counts look controlled, and troublesome itching or fatigue can lead to changes in treatment, so describe them clearly at visits.
About 1 in 8 people have a blood clot before they are diagnosed.21PubMed Central. Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States Doctors class you as high risk if you are over 60 or have had a clot, and low risk otherwise.22PubMed. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management Your risk group shapes treatment, from blood removal and aspirin to medicines that lower counts.
Clots can form in arteries, causing heart attacks or strokes, or in veins, such as in the legs or abdomen. Chest pain, one-sided weakness, or slurred speech need emergency care. A swollen, painful leg may be a vein clot, and sudden belly pain can signal a clot in the abdominal veins.

